222 related articles for article (PubMed ID: 26721295)
1. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
Babic A; Wolpin BM
Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
[No Abstract] [Full Text] [Related]
2. Early detection and imaging strategies to reveal and target developing pancreatic cancer.
Crawford HC; Wallace MB; Storz P
Expert Rev Anticancer Ther; 2020 Feb; 20(2):81-83. PubMed ID: 31986932
[No Abstract] [Full Text] [Related]
3. Prognostic markers in pancreatic ductal adenocarcinomas.
Hezel AF; Bardeesy N
Cancer Biol Ther; 2008 Sep; 7(9):1360-1. PubMed ID: 18836287
[No Abstract] [Full Text] [Related]
4. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
[TBL] [Abstract][Full Text] [Related]
5. Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects.
Chari ST; Sharma A; Maitra A
Ann Intern Med; 2020 Apr; 172(8):558-559. PubMed ID: 32176886
[No Abstract] [Full Text] [Related]
6. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
7. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?
Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE
Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604
[No Abstract] [Full Text] [Related]
8. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes.
Massoumi RL; Hines OJ; Eibl G; King JC
Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240
[TBL] [Abstract][Full Text] [Related]
9. The role of exosomes in the pathogenesis of pancreatic ductal adenocarcinoma.
Robinson SM; Fan L; White SA; Charnley RM; Mann J
Int J Biochem Cell Biol; 2016 Jun; 75():131-9. PubMed ID: 27017975
[TBL] [Abstract][Full Text] [Related]
10. Markers of pancreatic cancer: working toward early detection.
Goggins M
Clin Cancer Res; 2011 Feb; 17(4):635-7. PubMed ID: 21304000
[TBL] [Abstract][Full Text] [Related]
11. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
[TBL] [Abstract][Full Text] [Related]
13. "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer.
Comandatore A; Balsano R; Immordino B; Arguedas D; Capula M; Baglio SR; Garajovà I; Malapelle U; Morelli L; Giovannetti E
Crit Rev Oncol Hematol; 2022 May; 173():103659. PubMed ID: 35398264
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
15. Urine test can detect early stage pancreatic cancer.
Bagcchi S
Lancet Oncol; 2015 Sep; 16(9):e431. PubMed ID: 26256762
[No Abstract] [Full Text] [Related]
16. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
17. Metastatic Pancreatic Cancer.
Hogendorf P; Durczyński A; Strzelczyk J
J Invest Surg; 2018 Apr; 31(2):151-152. PubMed ID: 28267398
[No Abstract] [Full Text] [Related]
18. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma.
Caputo D; Caracciolo G
Cancer Lett; 2020 Feb; 470():191-196. PubMed ID: 31783084
[TBL] [Abstract][Full Text] [Related]
19. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma.
Xu B; Chen Y; Peng M; Zheng JH; Zuo C
Int J Cancer; 2023 Jan; 152(2):110-122. PubMed ID: 35765844
[TBL] [Abstract][Full Text] [Related]
20. High-grade PanIN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer.
Yokode M; Akita M; Fujikura K; Kim MJ; Morinaga Y; Yoshikawa S; Terada T; Matsukiyo H; Tajiri T; Abe-Suzuki S; Itoh T; Hong SM; Zen Y
Histopathology; 2018 Aug; 73(2):247-258. PubMed ID: 29660164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]